bicalutamide and azd3514

bicalutamide has been researched along with azd3514 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Acton, DG; Bradbury, RH; Broadbent, NL; Brooks, AN; Carr, GR; Hatter, G; Hayter, BR; Hill, KJ; Howe, NJ; Jones, RD; Jude, D; Lamont, SG; Loddick, SA; McFarland, HL; Parveen, Z; Rabow, AA; Sharma-Singh, G; Stratton, NC; Thomason, AG; Trueman, D; Walker, GE; Wells, SL; Wilson, J; Wood, JM	1
Wang, S; Xiang, W	1

Reviews

1 review(s) available for bicalutamide and azd3514

Article	Year
Therapeutic Strategies to Target the Androgen Receptor. Journal of medicinal chemistry, 2022, 07-14, Volume: 65, Issue:13 Topics: Androgen Antagonists; Androgen Receptor Antagonists; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen	2022

Other Studies

1 other study(ies) available for bicalutamide and azd3514

Article	Year
Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer. Bioorganic & medicinal chemistry letters, 2013, Apr-01, Volume: 23, Issue:7 Topics: Animals; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Prostatic Neoplasms; Pyridazines; Receptors, Androgen; Small Molecule Libraries; Structure-Activity Relationship	2013

Article

Year

Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer.

Bioorganic & medicinal chemistry letters, 2013, Apr-01, Volume: 23, Issue:7

Topics: Animals; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Prostatic Neoplasms; Pyridazines; Receptors, Androgen; Small Molecule Libraries; Structure-Activity Relationship

2013